Skip to main content
SpringerLink
Log in

How to proceed with long-term anticoagulation in patient after total gastrectomy and atrial fibrillation?

  • Letter to the Editor
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Kirchhof P, Benussi S, Kotecha D et al (2016) ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J 37:2893–2962

    Article  PubMed  Google Scholar 

  2. Steffel J, Verhamme P, Potpara TS, Albaladejo P, Antz M, Desteghe L, Haeusler KG, Oldgren J, Reinecke H, Roldan-Schilling V, Rowell N, Sinnaeve P, Collins R, Camm AJ, Heidbüchel H, ESC Scientific Document Group (2018) The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation. Eur Heart J 39:1330–1393

    Article  CAS  PubMed  Google Scholar 

  3. Bolek T, Samoš M, Stančiaková L, Ivanková J, Škorňová I, Staško J, Galajda P, Kubisz P, Mokáň M (2017) The Impact of proton pump inhibition on dabigatran levels in patients with atrial fibrillation. Am J Ther. https://doi.org/10.1097/MJT.0000000000000599

  4. Kuwayama T, Osanai H, Ajioka M, Tokuda K, Ohashi H, Tobe A, Yoshida T, Masutomi T, Kambara T, Inoue Y, Nakashima Y, Asano H, Sakai K (2017) Influence of proton pump inhibitors on blood dabigatran concentrations in Japanese patients with non-valvular atrial fibrillation. J Arrhythm 33:619–623

    Article  PubMed  PubMed Central  Google Scholar 

  5. Ollier E, Hodin S, Basset T, Accassat S, Bertoletti L, Mismetti P, Delavenne X (2015) In vitro and in vivo evaluation of drug-drug interaction between dabigatran and proton pump inhibitors. Fundam Clin Pharmacol 29:604–614

    Article  CAS  PubMed  Google Scholar 

  6. Stangier J, Eriksson BI, Dahl OE et al (2005) Pharmacokinetic profile of the oral direct thrombin inhibitor dabigatran etexilate in healthy volunteers and patients undergoing total hip replacement. J Clin Pharmacol 45:555–563

    Article  CAS  PubMed  Google Scholar 

  7. Kreutz R (2014) Pharmacokinetics and pharmacodynamics of rivaroxaban--an oral, direct factor Xainhibitor. Curr Clin Pharmacol 9:75–83

    Article  CAS  PubMed  Google Scholar 

  8. Raghavan N, Frost CE, Yu Z, He K, Zhang H, Humphreys WG, Pinto D, Chen S, Bonacorsi S, Wong PC, Zhang D (2009) Apixaban metabolism and pharmacokinetics after oral administration to humans. Drug Metab Dispos 37:74–81

    Article  CAS  PubMed  Google Scholar 

  9. Ogata K, Mendell-Harary J, Tachibana M, Masumoto H, Oguma T, Kojima M, Kunitada S (2010) Clinical safety, tolerability, pharmacokinetics, and pharmacodynamics of the novel factor Xa inhibitor edoxaban in healthy volunteers. J Clin Pharmacol 50:743–753

    Article  CAS  PubMed  Google Scholar 

  10. Rottenstreich A, Barkai A, Arad A, Raccah BH, Kalish Y (2018) The effect of bariatric surgery on direct-acting oral anticoagulant drug levels. Thromb Res 163:190–195

    Article  CAS  PubMed  Google Scholar 

  11. Reilly PA, Lehr T, Haertter S et al (2014) RE-LY investigators. The effect of dabigatran plasma concentrations and patient characteristics on the frequency of ischemic stroke and major bleeding in atrial fibrillation patients: the RE-LY Trial (randomized evaluation of long-term anticoagulation therapy). J Am Coll Cardiol 63:321–328

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

The authors would like to thank Mr. Paul McCullough for proofreading.

Funding

This study was supported by project APVV (Slovak Research and Development Agency) 16-0020 and by research project UK/386/2018 of Comenius University in Bratislava.

Author information

Authors and Affiliations

  1. Department of Internal Medicine I, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Kollarova 2, 036 59, Martin, Slovak Republic

    Tomáš Bolek, Matej Samoš, Barbora Korpallová, Peter Galajda & Marián Mokán

  2. National Centre of Hemostasis and Thrombosis, Department of Hematology and Blood Transfusion, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Martin, Slovak Republic

    Ingrid Škorňová, Lucia Stančiaková, Ján Staško & Peter Kubisz

Authors
  1. Tomáš Bolek
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Matej Samoš
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ingrid Škorňová
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Lucia Stančiaková
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Barbora Korpallová
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Peter Galajda
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Ján Staško
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Peter Kubisz
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Marián Mokán
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Matej Samoš.

Ethics declarations

Conflict of interest

The authors declare that they have no conflicts of interest.

Ethical approval and inform consent

This research was done according to ethical standards and was approved by the local ethical committee (Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava). The patient agreed to participate in the research and signed an informed consent for study participation.

Electronic supplementary material

ESM 1

(DOCX 91 kb)

ESM 2

(DOCX 82 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bolek, T., Samoš, M., Škorňová, I. et al. How to proceed with long-term anticoagulation in patient after total gastrectomy and atrial fibrillation?. Eur J Clin Pharmacol 75, 285–286 (2019). https://doi.org/10.1007/s00228-018-2571-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00228-018-2571-9

Search

Navigation